Want to see SONX full AI Analyst Report?
SONX Stock Chart & Stats
$1.00
$0.00(0.00%)
At close: 4:00 PM EDT
$1.00
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.02 - $1.90
Previous CloseN/A
Volume1.00
Average Volume (3M)305.00
Market Cap
$547.07K
Enterprise Value$6.93M
Total Cash (Recent Filing)$11.63M
Total Debt (Recent Filing)$18.93M
Price to Earnings (P/E)―
Beta-0.56
Next Earnings
Mar 23, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.36
Shares Outstanding427,401
10 Day Avg. Volume0
30 Day Avg. Volume305
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.62
Price to Sales (P/S)0.05
P/FCF Ratio-0.13
Enterprise Value/Market Cap12.66
Enterprise Value/Revenue0.22
Enterprise Value/Gross Profit0.58
Enterprise Value/Ebitda-0.25
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-46.56
Revenue Forecast (FY)$42.30M
Bulls Say, Bears Say
Bulls Say
Loss ReductionThe narrowing net loss indicates meaningful cost control and/or mix improvement. If maintained, this progress could reduce the earnings gap and improve Sonendo’s ability to scale its dental technology business while moving toward profitability.
Debt ReductionDebt fell substantially over the period, reducing the absolute repayment burden. Although capitalization remains weak, lower debt can improve financial flexibility and lessen financing pressure as Sonendo works toward sustainable profitability.
Recurring Consumables ModelConsumables create a recurring revenue component beyond initial equipment sales, with revenue linked to procedures performed on installed consoles. Greater practice utilization could therefore support repeat sales and deepen the platform’s commercial value over time.
Bears Say
Revenue ContractionRevenue declined in both reported years, showing that the business has not established durable top-line expansion. Continued contraction can limit operating leverage, weaken reinvestment capacity, and make it harder to scale the GentleWave platform.
Negative Stockholders’ EquityNegative stockholders’ equity is a major capitalization weakness that reduces financial flexibility. It leaves less balance-sheet cushioning if operating losses continue and can constrain Sonendo’s ability to fund growth, absorb setbacks, or negotiate from a strong financial position.
Persistent Negative Cash FlowPersistent negative operating and free cash flow means Sonendo has not yet demonstrated self-funding operations. Even with improved cash burn, continued consumption can require external funding or balance-sheet capacity, limiting investment flexibility until cash generation turns sustainably positive.
Sonendo News
SONX FAQ
What was Sonendo’s price range in the past 12 months?
Sonendo lowest stock price was $0.02 and its highest was $1.90 in the past 12 months.
What is Sonendo’s market cap?
Sonendo’s market cap is $547.07K.
When is Sonendo’s upcoming earnings report date?
Sonendo’s upcoming earnings report date is Mar 23, 2027 which is in 143 days.
How were Sonendo’s earnings last quarter?
Sonendo released its earnings results on Mar 26, 2025. The company reported -$13.35 earnings per share for the quarter, missing the consensus estimate of -$13.04 by -$0.31.
Is Sonendo overvalued?
According to Wall Street analysts Sonendo’s price is currently Overvalued.
Does Sonendo pay dividends?
Sonendo does not currently pay dividends.
What is Sonendo’s EPS estimate?
Sonendo’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sonendo have?
Sonendo has 427,401 shares outstanding.
What happened to Sonendo’s price movement after its last earnings report?
Sonendo reported an EPS of -$13.35 in its last earnings report, missing expectations of -$13.04. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Sonendo?
Currently, no hedge funds are holding shares in SONX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sonendo
Sonendo, Inc. operates as a commercial-stage medical technology firm, dedicated to innovating, producing, and marketing advanced devices for root canal treatment across the United States and Canada. A flagship offering is GentleWave, an innovative device for addressing tooth decay that meticulously cleans and sanitizes the intricate microscopic passages within teeth without the need for removing any natural tooth structure. The company's product line also features SoundSeal, a specialized material used to construct and seal dental crowns, alongside its proprietary Sonendo-branded liquid solution of EDTA, which assists in the debridement and disinfection processes crucial for root canal systems. Furthermore, Sonendo provides "The Digital Office," a comprehensive practice management software solution designed to foster an integrated digital environment for dental professionals. Established in 2006, the organization was initially known as Dentatek Corporation before officially rebranding to Sonendo, Inc. in March 2011. Its corporate headquarters are situated in Laguna Hills, California.
Technical Analysis
Ownership Overview
―
Insiders
1.08% Mutual Funds
― Other Institutional Investors
98.92% Public Companies and
Individual Investors